We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.
- Authors
Furrie, E; Macfarlane, S; Kennedy, A; Cummings, J H; Walsh, S V; O'neil, D A; Macfarlane, G T
- Abstract
Ulcerative colitis (UC) is an acute and chronic inflammatory disease of the large bowel with unknown aetiology. The immune response against normal commensal microorganisms is believed to drive inflammatory processes associated with UC. Therefore, modulation of bacterial communities on the gut mucosa, through the use of probiotics and prebiotics, may be used to modify the disease state.
- Publication
Gut, 2005, Vol 54, Issue 2, p242
- ISSN
0017-5749
- Publication type
Journal Article
- DOI
10.1136/gut.2004.044834